Full history for every metric is available with a Kvantra account
Societal CDMO, Inc. (SCTL)
Key financial summary
Financials in USD| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | TTM | ||
|---|---|---|---|---|---|---|---|---|
| Total revenue | $m | 77 | 99 | 66 | 75 | 90 | 95 | 95 |
| Operating profit | $m | -2 | -2 | |||||
| Net profit | $m | -80 | -38 | -47 | -27 | -20 | -13 | -13 |
| EPS reported | $ | -0.14 | -0.15 | |||||
| Operating cashflow per share | $ | -0.04 | -0.04 | |||||
| Capex per share | $ | 0.09 | 0.09 | |||||
| FCF per share | $ | -0.12 | -0.12 | |||||
| Free cash flow | $m | -12 | -9 | |||||
| Net debt | $m | 73 | 30 | |||||
| Book value equity | $m | 59 | 59 | |||||
| Book value per share | $ | 0.62 | 0.56 | |||||
| Number of shares | m | 95.23 | 104.86 | |||||
| DPS (TTM paid) | $ | 0.00 | 0.00 |
Financial summary
Financials in USD| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | TTM | ||
|---|---|---|---|---|---|---|---|---|
| Value | ||||||||
| P/E TTM | x | - | - | |||||
| P/B LTM | x | 0.57 | 1.98 | |||||
| P/S LTM | x | 0.35 | 1.23 | |||||
| P/FCF LTM | x | -2.88 | -12.36 | |||||
| EV/EBITDA LTM | x | 14.92 | 82.29 | |||||
| EV/Sales LTM | x | 1.13 | 1.55 | |||||
| Earnings Yield LTM | % | -39.77% | -12.67% | |||||
| FCF Yield | % | -34.68% | -8.09% | |||||
| Quality | ||||||||
| ROE | % | -22.63% | -22.40% | |||||
| ROIC | % | -1.24% | -1.24% | |||||
| Operating margin | % | -1.86% | -1.86% | |||||
| Gross margin | % | 19.54% | 19.54% | |||||
| FCF/Sales | % | -12.23% | -12.23% | |||||
| Growth and momentum | ||||||||
| EPS Growth YoY | % | - | - | |||||
| Sales Growth YoY | % | +4.90% | +4.90% | |||||
| Net Income Growth YoY | % | - | - | |||||
| FCF Growth | % | - | - | |||||
| Operating Profit Growth | % | - | - | |||||
| Dividend and capital structure | ||||||||
| Dividend Yield | % | 0.00% | 0.00% | |||||
| Dividend Growth | % | 0.00% | 0.00% | |||||
| Payout Ratio | % | 0.00% | 0.00% | |||||
| FCF/Debt | x | -0.14 | -0.12 | |||||
| Net Debt/EBITDA | x | 10.25 | 10.25 | |||||
| EBIT/Net interest | x | -0.18 | -0.18 | |||||
| Net debt/market cap | % | 219.51% | 25.92% | |||||
| Net debt/Equity | x | 1.25 | 0.51 | |||||
| Gross debt/equity | x | 1.39 | 1.39 | |||||
Company overview
Societal CDMO, Inc., an organization founded in Exton, Pennsylvania, in 2007, functions as a contract development and manufacturing partner for the global pharmaceutical industry. Formerly known as Recro Pharma, Inc. until its name change in March 2022, the company specializes in supporting small molecule therapeutic advancements. Its comprehensive services span the entire drug development lifecycle, from initial research and development to manufacturing and packaging various therapeutic dosage forms for both domestic and international markets. Key offerings include drug development expertise, end-to-end regulatory guidance, clinical and commercial scale production, sterile fill/finish operations, freeze-drying (lyophilization), and integrated packaging and logistics solutions.
Similar companies
For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.
Societal CDMO, Inc. (SCTL)
Societal CDMO, Inc., an organization founded in Exton, Pennsylvania, in 2007, functions as a contract development and manufacturing partner for the global pharmaceutical industry. Formerly known as Recro Pharma, Inc. until its name change in March 2022, the company specializes in supporting small molecule therapeutic advancements. Its comprehensive services span the entire drug development lifecycle, from initial research and development to manufacturing and packaging various therapeutic dosage forms for both domestic and international markets. Key offerings include drug development expertise, end-to-end regulatory guidance, clinical and commercial scale production, sterile fill/finish operations, freeze-drying (lyophilization), and integrated packaging and logistics solutions.
Unlock all fundamental data
Sign up for FreeUnlock all fundamental data
Sign up for Free